17.beta.-estradiol/levonorgestrel transderm patch for...

Details 17.beta.-estradiol/levonorgestrel transderm patch for... 17.beta.-estradiol/levonorgestrel transderm patch for...

A - Human Necessities

61

K

A61K 31/565 (2006.01) A61K 9/70 (2006.01) A61K 31/57 (2006.01) A61P 5/30 (2006.01) A61P 5/34 (2006.01)

Patent

CA 2495055

The present invention relates to a method for reducing triglyceride levels in a patient and effecting hormone replacement therapy comprising continuously and transdermally administering an essentially constant therapeutically effective amount of a composition comprising an estradiol (17.beta.-estradiol) and a progestin (levonorgestrel (LNG)) in a pharmaceutically acceptable carrier.

La présente invention concerne une méthode de diminution des niveaux de triglycéride chez un patient et de réalisation d'une hormonothérapie substitutive qui consiste à administrer en continu et au niveau transdermique une quantité efficace thérapeutiquement pratiquement constante d'une composition contenant un oestradiol (17.beta.-oestradiol) et une progestine (lévonorgestrel (LNG)) dans un excipient acceptable sur le plan pharmaceutique.

Affiliated with

Also associated with

Rating

17.beta.-estradiol/levonorgestrel transderm patch for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 17.beta.-estradiol/levonorgestrel transderm patch for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17.beta.-estradiol/levonorgestrel transderm patch for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1799084